Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
Grantová podpora
Howard Hughes Medical Institute - United States
PubMed
19782655
DOI
10.1016/j.bcp.2009.09.019
PII: S0006-2952(09)00798-9
Knihovny.cz E-zdroje
- MeSH
- antitumorózní látky chemie metabolismus farmakologie MeSH
- buněčná membrána účinky léků metabolismus MeSH
- cyklohexylaminy chemie metabolismus farmakologie MeSH
- DNA nádorová metabolismus MeSH
- glutathion metabolismus MeSH
- HeLa buňky MeSH
- králíci MeSH
- lidé MeSH
- ligandy MeSH
- nádorové buněčné linie MeSH
- nosiče léků chemie metabolismus toxicita MeSH
- oprava DNA účinky léků fyziologie MeSH
- organoplatinové sloučeniny metabolismus toxicita MeSH
- skot MeSH
- sloučeniny platiny chemie metabolismus toxicita MeSH
- zvířata MeSH
- Check Tag
- králíci MeSH
- lidé MeSH
- skot MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Názvy látek
- 1,4-diaminocyclohexane MeSH Prohlížeč
- antitumorózní látky MeSH
- cyklohexylaminy MeSH
- DNA nádorová MeSH
- glutathion MeSH
- ligandy MeSH
- nosiče léků MeSH
- organoplatinové sloučeniny MeSH
- platinum chloride MeSH Prohlížeč
- sloučeniny platiny MeSH
Earlier studies have described promising antitumor activity of a large-ring chelate complex [PtCl(2)(cis-1,4-DACH)] (DACH=diaminocyclohexane). Encouraging antitumor activity of this analogue of cisplatin prompted us to perform studies focused on the mechanistic basis of pharmacological effects of this complex. Four early steps in the mechanism of biological activity of cisplatin have been delineated: cell entry, reactions with sulfur-containing compounds, platinum-DNA binding along with processing platinated DNA by proteins (enzymes) and DNA repair. Here, we describe comparative experiments (involving also cisplatin) revealing: (i) improved cytotoxicity (3.4-5.4-fold) of [PtCl(2)(cis-1,4-DACH)] in human tumor ovarian cell lines; (ii) enhanced cellular uptake (approximately 1.5-fold) of [PtCl(2)(cis-1,4-DACH)]; (iii) somewhat enhanced rate of reactions of [PtCl(2)(cis-1,4-DACH)] with glutathione (approximately 1.5-fold), but a similar rate of reactions with metallothionenin-2; (iv) enhanced rate of DNA binding of [PtCl(2)(cis-1,4-DACH)] in cell-free media (approximately 2-fold); (v) similar sequence preference of DNA binding of [PtCl(2)(cis-1,4-DACH)] in cell-free media; (vi) identical DNA interstrand cross-linking efficiency (6%); (vii) similar bending (32 degrees) and enhanced local unwinding (approximately 1.5-fold) induced in DNA by the major 1,2-GG-intrastrand cross-link; (viii) markedly enhanced inhibiting effects of DNA adducts of [PtCl(2)(cis-1,4-DACH)] on processivity of DNA polymerase; and (ix) a slightly lower efficiency of DNA repair systems to remove the adducts of [PtCl(2)(cis-1,4-DACH)] from DNA.
Citace poskytuje Crossref.org